Neoadjuvant and adjuvant trials in non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 65, Issue 1, 1998, Pages 208-211

  Einhorn, Lawrence H ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b Indiana Cancer Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; LOMUSTINE; MITOMYCIN C; NAVELBINE; PACLITAXEL; VINCRISTINE; VINDESINE;

ATELECTASIS; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; LUNG NON SMALL CELL CANCER; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0031883132     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(97)01150-8     Document Type: Conference Paper

References (22)

1. 1. Einhorn LH. Neoadjuvant therapy of stage III non-small cell lung cancer. Ann Thorac Surg 1988;46:362-5.
2. 2. Edelman MJ, Gandara DR, Roach M, Benfield JR. Multimodality therapy in stage III non-small cell lung cancer. Ann Thorac Surg 1996;61:1564-72.
3. 3. Kirsh MM, Rotman H, Argenta L, et al. Carcinoma of the lung: results of treatment over 10 years. Ann Thorac Surg 1976;21:371-7.
4. 4. Green N, Kurohara SS, George FW, Crews QE. Postresection irradiation for primary lung cancer. Radiology 1975;116: 405-7.
5. 5. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med 1987; 315:1377-81.
6. 0 disease. Br J Cancer 1996;74:632-9.
7. 7. Holmes EC, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma. J Clin Oncol 1986;4:710-5.
8. 8. Niiranen A, Niitamo-Korhonen S, Kouri M, et al. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomized study. J Clin Oncol 1992;10:1927-32.
9. 9. Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with CAP in patients with completely resected stage I non-small cell lung cancer. J Natl Cancer Inst 1993;85:299-306.
10. 10. Pisters KMW, Kris MG, Gralla RJ, et al. Randomized trial of adjuvant vindesine plus cisplatin in patients with operable stage III non-small cell lung cancer. J Surg Oncol 1994;56: 236-41.
11. 11. Ohta M, Tsuchiya R, Shimoyama M, et al. Adjuvant chemotherapy for completely resected stage III NSCLC. J Thorac Cardiovasc Surg 1993;106:703-8.
12. 12. Dautzenberg B, Chastang C, Arriagada R, et al. Adjuvant radiotherapy versus combined chemotherapy followed by radiotherapy in the treatment of resected NSCLC. Cancer 1995;76:779-86.
13. 13. Rosell R, Gómez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994;330:153-8.
14. 14. Roth JA, Fossella F, Kornaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA NSCLC. J Natl Cancer Inst 1994;86:673-80.
15. 15. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna J. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992;53:992-8.
16. 16. Yoneda S, Hibino S, Gotoh I, et al. A comparative trial on induction chemoradiotherapy followed by surgery or immediate surgery for stage III NSCLC [Abstract]. Proc Am Soc Clin Oncol 1995;14:367.
17. 2 NSCLC [Abstract]. Proc Am Soc Clin Oncol 1997;16:448.
18. 18. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative therapy for primary breast cancer on local-regional disease, disease-free survival and survival: results from NSABP B-18 [Abstract]. Proc Am Soc Clin Oncol 1997;16:127.
19. 19. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
20. 20. Langer CJ, Leighton JC, Comis RL, et al. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis. J Clin Oncol 1995;13:1860-70.
21. 21. Wozniak AJ, Crowley JJ, Bakerzak GR, et al. Phase III trial of cisplatin versus cisplatin + navelbine in advanced NSCLC: a SWOG study [Abstract]. Proc Am Soc Clin Oncol 1996;15: 374.
22. 22. Bonomi P, Kim K, Chang A, et al. Phase III trial of cisplatin + VP-16 versus cisplatin + taxol in advanced NSCLC: an ECOG trial. Proc Am Soc Clin Oncol 1996;15:382.